GPT and metabolic dysfunction-associated steatohepatitis: The Executive Council of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) recommended a liver biopsy in children at risk of NASH and/or advanced fibrosis, considering risk factors such as the presence of type 2 diabetes, splenomegaly, ALT > 80 U/L, AST/ALT > 1 and disease-related panhypopituitarism.